Dapagliflozin for chronic heart failure with reduced ejection fraction: NICE TA679
Posted 2 Nov 2021
Dr Anish Kotecha outlines the recent technology appraisal regarding the use of dapagliflozin as an add-on to optimised standard care for chronic heart failure with reduced ejection fraction.
Create an account to add page annotations
Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page